reference/36003258

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36003258

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	666
issn	0001-6322 1432-0533
issueIdentifier	5
pageRange	651-666
publicationName	Acta Neuropathologica
startingPage	651
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_88ce56907d3ab0c87a97248a5168e32e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0071671e0d5c2067c0c3bc602c6c15de
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_604a0b2d946758ddb24ff68dd90514da http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b52c675333754dcf7450b4484808975b
bibliographicCitation	Goddard J, Castle J, Southworth E, Fletcher A, Crosier S, Martin-Guerrero I, García-Ariza M, Navajas A, Masliah-Planchon J, Bourdeaut F, Dufour C, Ayrault O, Goschzik T, Pietsch T, Sill M, Pfister SM, Rutkowski S, Richardson S, Hill RM, Williamson D, Bailey S, Schwalbe EC, Clifford SC, Hicks D. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification. Acta Neuropathol. 2023 Apr 04;145(5):651–66. doi: 10.1007/s00401-023-02566-0.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ad86ca8633164c0beed2fd788fdb039 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dbf6e745c529e8b99217521a5f1eabb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8573-8009 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fe636f3907348393cf803d2c08d60d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5847278a9b6e1bc54f974f673c2daee2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e300d200c5bed922ae6eee7baa6a9ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9454ae4cb05902dcae02cff039e4279 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f4e44d262be276af7f5b2a025a34bb1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4773aa8527a2dce9df814794ce7b2311 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31fdffa862b8c5332f1ca530a2397d2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_289657650830b41ad196df57d344e68a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d543a09bd2e9b32f73b008b6e8ef1d07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_392b93564d95522d5027ca3034cf6bc2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a042a403135abb7f4e28cfa755ba259 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fa14b5a75f1aae9e82642e6d97327b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cca3100945fad1bae229b0c2ab0356d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ca4edbdba10890bbead3615338bc996 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e68fecfb524b3de6aa562de8c501349 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f5fbeb34d9c08be38d4f666b79a3938 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb4a4f4823287ac36b5b457a9c878584 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88cc8137229347f226c363f77cac3ca0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6676992f740f6ea13c144ac020cbf8d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_082ba39bd9be8650ec17c09716281ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0de1a1a0786c0496009a3bb16930466d
date	2023-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00401-023-02566-0 https://pubmed.ncbi.nlm.nih.gov/PMC10119222 https://pubmed.ncbi.nlm.nih.gov/37014508
isPartOf	https://portal.issn.org/resource/ISSN/0001-6322 https://portal.issn.org/resource/ISSN/1432-0533 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/133
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6891 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10256 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8443 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7277 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10163 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d876b31399be575129188ea7b662c4f2

Total number of triples: 59.